Company intelligence / Profile preview

Panamerican Biotecnologia

Porto Alegre, Rio Grande do Sul, Brazil

Ownership: Private
Development stage: Other

Overview

Panamerican Biotecnologia is a Brazilian biotechnology company specializing in the development and manufacture of veterinary biologics, with a primary focus on Foot-and-Mouth Disease (FMD) vaccines. Based in Porto Alegre, the company operates high-containment manufacturing facilities dedicated to producing high-potency antigens and finished vaccine products for the livestock industry. Since its acquisition by Merial (now part of Boehringer Ingelheim), the site has served as a strategic hub for animal health solutions in Latin America. The company's expertise spans large-scale cell culture, viral inactivation, and formulation of oil-adjuvanted vaccines.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologic
Industry: Veterinary

Beyond the preview

Go deeper on Panamerican Biotecnologia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Panamerican Biotecnologia.

Explore the full profile